Clinical-stage biotech companies

Companies whose enriched business profile is tagged “Clinical-stage biotech”, drawn from their SEC filings + website text. Sorted by market capitalization; every figure is delayed data from SEC EDGAR + Finnhub, shown with its as-of date.

• IMMUNOVANT INC (IMVT) Health Care — Immunovant is a clinical-stage immunology company developing IMVT-1402, a potentially best-in-class FcRn inhibitor to treat autoimmune diseases driven by pathogenic IgG antibodies. ask →
• TREVI THERAPEUTICS INC (TRVI) Health Care — Clinical-stage biopharmaceutical company developing Haduvio (oral nalbuphine ER), a KAMA receptor modulator targeting chronic cough in idiopathic pulmonary fibrosis and other lung conditions. ask →
• TYRA BIOSCIENCES INC (TYRA) Health Care — Tyra is a precision oncology company developing targeted small-molecule drugs for genetically-defined cancers with novel mechanisms of action. ask →
• ATAIBECKLEY INC (ATAI) Health Care — AtaiBeckley is a clinical-stage biotech company advancing controlled-substance-derived therapeutics to treat CNS and psychiatric disorders. ask →
• ANNEXON INC (ANNX) Health Care — A clinical-stage biotech company developing complement pathway-targeted therapies for severe neurological and autoimmune disorders. ask →
• DESIGN THERAPEUTICS INC (DSGN) Health Care — Design Therapeutics is a clinical-stage biotech company pioneering GeneTAC® small molecules to treat rare genetic diseases like Friedreich ataxia. ask →
• ALTO NEUROSCIENCE INC (ANRO) Health Care — A clinical-stage biotech company developing psychiatric and neurological treatments using proprietary biomarker discovery to identify and treat patient subpopulations. ask →
• CLIMB BIO INC (CLYM) Health Care — Clinical-stage biotech developing budoprutug, an anti-CD19 monoclonal antibody for B-cell depletion in autoimmune diseases including membranous nephropathy and lupus. ask →
• ZURA BIO LTD CLASS A (ZURA) Health Care — Zura Bio is developing differentiated bispecific and monoclonal antibodies targeting immune pathways in autoimmune and inflammatory diseases where current therapies leave patients with inadequate disease control. ask →
• REZOLUTE INC (RZLT) Health Care — Rezolute is a clinical-stage biotech company developing novel therapeutics for metabolic and inflammatory diseases. ask →
• UPSTREAM BIO INC (UPB) Health Care — Upstream Bio is developing verekitug, a highly potent TSLP receptor antagonist monoclonal antibody targeting severe respiratory inflammatory diseases with extended quarterly dosing intervals. ask →
• PERSPECTIVE THERAPEUTICS INC (CATX) Health Care — A targeted alpha therapy biotech advancing novel oncology candidates through clinical development toward potential FDA approval and commercialization. ask →

Not quite it? Describe exactly what you want →

Data: SEC EDGAR (filings) + Finnhub (fundamentals, delayed daily-close). Figures shown with their as-of date.

Last updated 2026-07-10.

Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date.